Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Clinical trial NCT01044069 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01044069
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-05
- Primary completion
- 2027-01-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.